Breaking News, Collaborations & Alliances

Micropore, InnoCore Enter Injectable Drugs Collaboration

Will deploy encapsulation technology in the production of a new generation of long acting injectables

By: Contract Pharma

Contract Pharma Staff

UK-based particle engineering specialist Micropore Technologies has entered a collaboration and license agreement with InnoCore Technologies BV, to deploy its patented technology, for the manufacture of InnoCore’s SynBiosys long acting injectable drugs.   Based in Groningen, The Netherlands, InnoCore has developed sophisticated biodegradable polymer formulation technologies for long acting injectable, sustained release microparticle-based drug delivery products. Its SynBiosys biodegradable polym...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters